Skip to the page

Data / Drug companies / Valerian root, passiflora, magnesium carbonate

Valerian root, passiflora, magnesium carbonate: 3 companies and 3 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Valerian root, passiflora, magnesium carbonate is listed in the FDA National Drug Code Directory by 3 companies, with 3 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on November 16, 2011.

The request: Get every company that lists valerian root, passiflora, magnesium carbonate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
3
Products
3
Generic (ANDA) products
0 (0.0%)
Application numbers
0
Routes
Oral
Brand names
Valerin, Relax Am-Pm, Formula 303
openFDA record search
api.fda.gov

Companies that list valerian root, passiflora, magnesium carbonate

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Dee Cee Laboratories1tabletUnapproved homeopathic productsSeptember 19, 1990
Foster Regal Laboratories1tabletUnapproved homeopathic productsNovember 16, 2011
Wonder Laboratories1tabletUnapproved homeopathic productsJune 12, 1986

Dosage forms

Dosage formProductsShare
Tablet3100%

Marketing categories

Marketing categoryProductsShare
Unapproved homeopathic products3100%

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.